Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:2434-2442
Published online before print November 13, 2006, doi: 10.1161/CIRCULATIONAHA.106.633735
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
114/23/2434    most recent
CIRCULATIONAHA.106.633735v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Atienza, F.
Right arrow Articles by Berenfeld, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atienza, F.
Right arrow Articles by Berenfeld, O.
Related Collections
Right arrow Electrophysiology
Right arrow Ablation/ICD/surgery
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2006;114:2434-2442.)
© 2006 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Activation of Inward Rectifier Potassium Channels Accelerates Atrial Fibrillation in Humans

Evidence for a Reentrant Mechanism

Felipe Atienza, MD, PhD; Jesús Almendral, MD, PhD; Javier Moreno, MD; Ravi Vaidyanathan, MS; Arkazdi Talkachou, MS; Jérôme Kalifa, MD; Angel Arenal, MD; Julian P. Villacastín, MD, PhD; Esteban G. Torrecilla, MD, PhD; Ana Sánchez, MD; Robert Ploutz-Snyder, PhD; José Jalife, MD; Omer Berenfeld, PhD

From Hospital General Universitario Gregorio Marañón (F.A., J.A., J.M., A.A., J.P.V., E.T., A.S.) and Hospital Clínico San Carlos (J.M., J.P.V.), Madrid, Spain, and Institute for Cardiovascular Research, SUNY Upstate Medical University, Syracuse, NY (R.V., A.T., J.K., R.P.-S., J.J., O.B.).

Correspondence to José Jalife, MD, Institute for Cardiovascular Research, SUNY Upstate Medical University, 766 Irving Ave, Syracuse, NY 13210. E-mail jalifej{at}upstate.edu

Received August 31, 2005; de novo received April 17, 2006; revision received September 19, 2006; accepted September 25, 2006.

Background— It is unclear whether atrial fibrillation (AF) drivers in humans are focal or reentrant. To test the hypothesis that functional reentry is involved in human AF maintenance, we determined the effects of adenosine infusion on local dominant frequency (DF) at different atrial sites. By increasing inward rectifier potassium channel conductance, adenosine would increase DF of reentrant drivers but decrease it in the case of a focal mechanism.

Methods and Results— Thirty-three patients were studied during AF (21 paroxysmal, 12 persistent) using recordings from each pulmonary vein–left atrial junction (PV-LAJ), high right atrium, and coronary sinus. DFs were determined during baseline and peak adenosine effect. In paroxysmal AF, adenosine increased maximal DF at each region compared with baseline (PV-LAJ, 8.03±2.2 versus 5.7±0.8; high right atrium, 7±2.2 versus 5.4±0.7; coronary sinus, 6.6±1.1 versus 5.3±0.7 Hz; P=0.001) and increased the left-to-right DF gradient (P=0.007). In contrast, in persistent AF, adenosine increased DF only in the high right atrium (8.33±1.1 versus 6.8±1.2 Hz; P=0.004). In 4 paroxysmal AF patients, real-time DF mapping of the left atrium identified the highest DF sites near the PV-LAJ, where adenosine induced an increase in DF (6.7±0.29 versus 4.96±0.26 Hz; P=0.008). Finally, simulations demonstrate that the frequency of reentrant drivers accelerates proportionally to the adenosine-modulated inward rectifier potassium current.

Conclusions— Adenosine accelerates drivers and increases frequency differently in paroxysmal compared with persistent human AF. The results strongly suggest that AF is maintained by reentrant sources, most likely located at the PV-LAJ in paroxysmal AF, whereas non-PV locations are more likely in persistent AF.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
EuropaceHome page
A. Bollmann, D. Husser, M. Stridh, F. Holmqvist, A. Roijer, C. J. Meurling, L. Sornmo, and S. B. Olsson
Atrial fibrillatory rate and risk of left atrial thrombus in atrial fibrillation
Europace, August 1, 2007; 9(8): 621 - 626.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al.
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society.
Europace, June 1, 2007; 9(6): 335 - 379.
[Full Text] [PDF]